Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1079

1.

Cell-based interventions for neurologic conditions: ethical challenges for early human trials.

Mathews DJ, Sugarman J, Bok H, Blass DM, Coyle JT, Duggan P, Finkel J, Greely HT, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Regenberg A, Siegel AW, Smith K, Solter D, Song H, Vescovi A, Young W, Gearhart JD, Faden R.

Neurology. 2008 Jul 22;71(4):288-93. doi: 10.1212/01.wnl.0000316436.13659.80. Review.

PMID:
18463365
3.

World Federation of Neurology position paper on human stem cell research.

World Federation of Neurology..

J Neurol Sci. 2006 Apr 15;243(1-2):1-2. No abstract available.

PMID:
16628827
4.

Safety issues in cell-based intervention trials.

Dawson L, Bateman-House AS, Mueller Agnew D, Bok H, Brock DW, Chakravarti A, Greene M, King PA, O'Brien SJ, Sachs DH, Schill KE, Siegel A, Solter D, Suter SM, Verfaillie CM, Walters LB, Gearhart JD, Faden RR.

Fertil Steril. 2003 Nov;80(5):1077-85. Review. Erratum in: Fertil Steril. 2004 Jan;81(1):226.

PMID:
14607552
5.

Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease.

Lo B, Parham L.

J Law Med Ethics. 2010 Summer;38(2):257-66. doi: 10.1111/j.1748-720X.2010.00486.x.

PMID:
20579249
6.

Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative.

Baer GR, Nelson RM; Ethics Group of the Newborn Drug Development Initiative..

Clin Ther. 2006 Sep;28(9):1399-407. Review.

PMID:
17062312
7.

Clinical trials in stem cell transplantation: guidelines for scientific and ethical review.

Lo B, Kriegstein A, Grady D.

Clin Trials. 2008;5(5):517-22. doi: 10.1177/1740774508096705. Review.

PMID:
18827044
8.

Ethics and stem cell therapeutics for cardiovascular disease.

Sugarman J.

Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):1-6. Review.

PMID:
17631433
9.

Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies.

Frank E, Novick DM, Kupfer DJ.

Psychopharmacology (Berl). 2003 Dec;171(1):19-26. Review.

PMID:
12721781
10.
11.

State payer mandates to cover care in US oncology trials: do science and ethics matter?

Taylor PL.

J Natl Cancer Inst. 2010 Mar 17;102(6):376-90. doi: 10.1093/jnci/djq028.

PMID:
20197514
12.

The impact of escalating regulatory requirements on the conduct of clinical research.

Gordon BG, Kessinger A, Mann SL, Prentice ED.

Cytotherapy. 2003;5(4):309-13. Review.

PMID:
12944237
13.

Working with the institutional review board.

Byerly WG.

Am J Health Syst Pharm. 2009 Jan 15;66(2):176-84. doi: 10.2146/ajhp070066. Review.

PMID:
19139484
14.
15.

Conflicts of interest in research involving human beings.

Greco D, Diniz NM.

J Int Bioethique. 2008 Mar-Jun;19(1-2):143-54, 202-3. Review.

PMID:
18664007
16.

Translating stem cell research: challenges at the research frontier.

Magnus D.

J Law Med Ethics. 2010 Summer;38(2):267-76. doi: 10.1111/j.1748-720X.2010.00487.x.

PMID:
20579250
17.

Stem-cell-derived products: an FDA update.

Moos M Jr.

Trends Pharmacol Sci. 2008 Dec;29(12):591-3. doi: 10.1016/j.tips.2008.09.003.

PMID:
18937983
18.

Analgesia and anesthesia for neonates: study design and ethical issues.

Anand KJ, Aranda JV, Berde CB, Buckman S, Capparelli EV, Carlo WA, Hummel P, Lantos J, Johnston CC, Lehr VT, Lynn AM, Maxwell LG, Oberlander TF, Raju TN, Soriano SG, Taddio A, Walco GA.

Clin Ther. 2005 Jun;27(6):814-43. Review.

PMID:
16117988
19.

Toward protecting the safety of participants in clinical trials.

Califf RM, Morse MA, Wittes J, Goodman SN, Nelson DK, DeMets DL, Iafrate RP, Sugarman J.

Control Clin Trials. 2003 Jun;24(3):256-71.

PMID:
12757992
20.

Ethics at phase 0: clarifying the issues.

Kimmelman J.

J Law Med Ethics. 2007 Winter;35(4):727-33, 514. Review.

PMID:
18076522

Supplemental Content

Support Center